000			01287 a2200373 4500
005			20250513044947.0
264		0	_c19950223
008			199502s 0 0 eng d
022			_a0042-9007
040			_aNLM _beng _cNLM
100	1		_aMosley, J W
245	0	0	_aHas hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States? _h[electronic resource]
260			_bVox sanguinis _c1994
300			_a12-5; discussion 24-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aDrug Contamination
650	0	4	_aFactor IX _xadverse effects
650	0	4	_aFactor VIII _xadverse effects
650	0	4	_aFamily Health
650	0	4	_aFemale
650	0	4	_aHemophilia A _xcomplications
650	0	4	_aHepatitis A _xepidemiology
650	0	4	_aHepatitis A Antibodies
650	0	4	_aHepatitis Antibodies _xblood
650	0	4	_aHepatovirus _xisolation & purification
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xblood
650	0	4	_aImmunoglobulin M _xblood
650	0	4	_aMale
650	0	4	_aPrevalence
650	0	4	_aTransfusion Reaction
650	0	4	_aUnited States _xepidemiology
773	0		_tVox sanguinis _gvol. 67 Suppl 4 _gp. 12-5; discussion 24-6
999			_c7831205 _d7831205